Zhang W, Scalori A, Fuh F, McBride J, et al. Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial. Inflamm Bowel Dis 2022 Apr 2. pii: 6562694. doi: 10.1093.
PMID: 35366308